Cargando…
Characterization of the Inflammatory Response to Severe COVID-19 Illness
Rationale: Coronavirus disease (COVID-19) is a global threat to health. Its inflammatory characteristics are incompletely understood. Objectives: To define the cytokine profile of COVID-19 and to identify evidence of immunometabolic alterations in those with severe illness. Methods: Levels of IL-1β,...
Autores principales: | McElvaney, Oliver J., McEvoy, Natalie L., McElvaney, Oisín F., Carroll, Tomás P., Murphy, Mark P., Dunlea, Danielle M., Ní Choileáin, Orna, Clarke, Jennifer, O’Connor, Eoin, Hogan, Grace, Ryan, Daniel, Sulaiman, Imran, Gunaratnam, Cedric, Branagan, Peter, O’Brien, Michael E., Morgan, Ross K., Costello, Richard W., Hurley, Killian, Walsh, Seán, de Barra, Eoghan, McNally, Cora, McConkey, Samuel, Boland, Fiona, Galvin, Sinead, Kiernan, Fiona, O’Rourke, James, Dwyer, Rory, Power, Michael, Geoghegan, Pierce, Larkin, Caroline, O’Leary, Ruth Aoibheann, Freeman, James, Gaffney, Alan, Marsh, Brian, Curley, Gerard F., McElvaney, Noel G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Thoracic Society
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7491404/ https://www.ncbi.nlm.nih.gov/pubmed/32584597 http://dx.doi.org/10.1164/rccm.202005-1583OC |
Ejemplares similares
-
Alpha-1 antitrypsin for cystic fibrosis complicated by severe cytokinemic COVID-19
por: McElvaney, Oliver J, et al.
Publicado: (2021) -
Prone positioning improves oxygenation and lung recruitment in patients with SARS-CoV-2 acute respiratory distress syndrome; a single centre cohort study of 20 consecutive patients
por: Clarke, Jennifer, et al.
Publicado: (2021) -
Reply to Blot et al. and to Inoue et al.
por: McElvaney, Oliver J., et al.
Publicado: (2021) -
A linear prognostic score based on the ratio of interleukin-6 to interleukin-10 predicts outcomes in COVID-19
por: McElvaney, Oliver J, et al.
Publicado: (2020) -
Corrigendum to ‘A linear prognostic score based on the ratio of interleukin-6 to interleukin-10 predicts outcomes in COVID-19’
por: McElvaney, Oliver J, et al.
Publicado: (2020)